2010
DOI: 10.1016/j.atherosclerosis.2009.10.045
|View full text |Cite
|
Sign up to set email alerts
|

The metabolic syndrome adds utility to the prediction of mortality over its components: The Vietnam Experience Study

Abstract: et al., (2010). The metabolic syndrome adds utility to the prediction of mortality over its components: the Vietnam Experience Study. Atherosclerosis, 210, 256-261. http://dx.doi.org/10.1016Atherosclerosis, 210, 256-261. http://dx.doi.org/10. /j.atherosclerosis.2009 . The metabolic syndrome adds utility to the prediction of mortality over its components:

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
9
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 28 publications
0
9
0
Order By: Relevance
“…To the best of our knowledge, this is the first study to show that optimal levels of 25(OH)D substantially reduce the risk of all-cause and cardiovascular mortality in subjects with the metabolic syndrome, a population well-known to exhibit excess mortality (14). We observed a 75% and 69% reduction in all-cause and cardiovascular disease mortality, respectively, in those with optimal levels compared with those with severe 25(OH)D deficiency.…”
Section: Discussionmentioning
confidence: 87%
See 2 more Smart Citations
“…To the best of our knowledge, this is the first study to show that optimal levels of 25(OH)D substantially reduce the risk of all-cause and cardiovascular mortality in subjects with the metabolic syndrome, a population well-known to exhibit excess mortality (14). We observed a 75% and 69% reduction in all-cause and cardiovascular disease mortality, respectively, in those with optimal levels compared with those with severe 25(OH)D deficiency.…”
Section: Discussionmentioning
confidence: 87%
“…Metabolic syndrome in adults was defined using the consensus statement from the International Diabetes Federation Task Force on Epidemiology and Prevention; the National Heart, Lung, and Blood Institute; the American Heart Association; the World Heart Federation; the International Atherosclerosis Society; and the International Association for the Study of Obesity (21). Specifically, it was identified in those having 3 or more of the following (1): blood pressure ≥130/85 mmHg or receiving antihypertensive medication (2); fasting glucose ≥5.6 mmol/L or receiving drug treatment for diabetes (3); triglycerides ≥1.7 mmol/L or receiving specific drug treatment (4); HDL cholesterol <1.03 mmol/L in men or <1.30 mmol/L in women or receiving specific drug treatment (5); or waist circumference >102 cm in men or >88 cm in women (21). …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In studies of adult persons, all‐cause mortality risk incrementally increases with the number of MetS components [35,36]. On the contrary, in studies of older person, both a dose–effect in both genders [13] and no association at all in either [17,20] were reported.…”
Section: Discussionmentioning
confidence: 99%
“…etabolic abnormalities, whether assessed as metabolic syndrome (MetS) [1] or as their single components (central obesity, impaired glucose metabolism, hypertension, hypertriglyceridaemia and lower high-density lipoprotein cholesterol (cHDL)) have been shown to increase cardiovascular (CV) morbidity and mortality [2][3][4][5]. Central obesity seems to play a crucial role in the origin of metabolic disruption, but many other mechanisms have also been considered responsible [6].…”
mentioning
confidence: 99%